This technology employs protein engineering to stabilize S in its prefusion conformation, preventing structural rearrangement, and exposing antigenically preferable surfaces. The technology has ...

Stocks of H5 vaccine that are antigenically related to circulating viruses are available and could be produced at scale using ...

Duke researchers have opened a new avenue in the attack against influenza viruses by creating a vaccine that encourages the immune system to target a portion of the virus surface that is less variable ...

A Vero-cell-culture–derived trivalent influenza vaccine had a protective efficacy of 79% against antigenically matched influenza strains. Conventional egg-based influenza vaccines have several ...

The first research programs attempting to develop an inactivated influenza vaccine, outside of the USSR, were conducted in England and in the USA at about the same time. However, it was at the ...